Another batch of blood pressure drugs have been recalled over fears they contain traces of a cancer-causing chemical.

Valsartan was originally developed by Novartis, marketed as Diovan, but it is now off patent and US patients can instead use generic versions from various companies around the world.

However, last summer it emerged some produced in China had been contaminated with a carcinogen called NDEA, prompting a global recall.

Read more


Related Articles


Comments